Your Account
Filter Articles
Sort
Categories
- #EMSPVirtual2021
- Associate members
- Document
- EMSP Events
- EMSP Events|EMSP News
- EMSP News
- EMSP News|From Europe
- EMSP News|From Europe|Stakeholder Events
- EMSP News|MS Research
- EMSP News|Press Releases
- EMSP News|Young People with MS
- From Europe
- From Europe|Member News
- From Europe|Stakeholder Events
- From Europe|Young People with MS
- Full members
- Full members|Member News
- Member News
- Member News|Young People with MS
- MS Research
- News – EMSP
- News2
- Press Releases
- Project Updates
- Stakeholder Events
- Uncategorized
- Young People with MS
Availability issues for approved drugs. Case study: Nabiximols
05.02.2017
By Harriet Doig MS Ireland includes the availability and reimbursement of MS drugs among its priorities as a patient organisation….
No crutches, no benefits: The disability assessment battle
05.02.2017
By Alina Verbnîi There are many battles facing people living with multiple sclerosis. In the Republic of Moldova, one of…
MS rehabilitation, a family programme
05.02.2017
By Pavel Zlobin This is a report about the construction and activity of an MS rehabilitation centre. It is also…
Providing modern MS rehabilitation
05.02.2017
By SPEM The Portuguese MS Society (SPEM) plans to relocate, expand and modernise the only rehabilitation centre in the country…
No crutches, no benefits: The disability assessment battle
05.02.2017
By Alina Verbnîi There are many battles facing people living with multiple sclerosis. In the Republic of Moldova, one of…
MS diagnosis testimony: I feared it was cancer
05.02.2017
By Labinot Demi My name is Labinot Demi, I live in Kosovo and I was diagnosed with multiple sclerosis in…
